HCSGD entry for BCL2
1. General information
Official gene symbol | BCL2 |
---|---|
Entrez ID | 596 |
Gene full name | B-cell CLL/lymphoma 2 |
Other gene symbols | Bcl-2 PPP1R50 |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network

3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0000209 | Protein polyubiquitination | IDA | biological_process |
GO:0001101 | Response to acid | IEA | biological_process |
GO:0001503 | Ossification | IEA | biological_process |
GO:0001541 | Ovarian follicle development | IEA | biological_process |
GO:0001656 | Metanephros development | IEA | biological_process |
GO:0001658 | Branching involved in ureteric bud morphogenesis | IEA | biological_process |
GO:0001662 | Behavioral fear response | IEA | biological_process |
GO:0001782 | B cell homeostasis | IEA | biological_process |
GO:0001836 | Release of cytochrome c from mitochondria | ISS NAS | biological_process |
GO:0001952 | Regulation of cell-matrix adhesion | IEA | biological_process |
GO:0002020 | Protease binding | IDA | molecular_function |
GO:0002320 | Lymphoid progenitor cell differentiation | IEA | biological_process |
GO:0002326 | B cell lineage commitment | IEA | biological_process |
GO:0002931 | Response to ischemia | IEA | biological_process |
GO:0003014 | Renal system process | IEA | biological_process |
GO:0005515 | Protein binding | IPI | molecular_function |
GO:0005634 | Nucleus | IDA | cellular_component |
GO:0005737 | Cytoplasm | IDA | cellular_component |
GO:0005739 | Mitochondrion | IDA | cellular_component |
GO:0005741 | Mitochondrial outer membrane | IDA TAS | cellular_component |
GO:0005783 | Endoplasmic reticulum | IDA | cellular_component |
GO:0005789 | Endoplasmic reticulum membrane | IEA | cellular_component |
GO:0005829 | Cytosol | IEA | cellular_component |
GO:0006470 | Protein dephosphorylation | IEA | biological_process |
GO:0006582 | Melanin metabolic process | IEA | biological_process |
GO:0006808 | Regulation of nitrogen utilization | IEA | biological_process |
GO:0006915 | Apoptotic process | TAS | biological_process |
GO:0006959 | Humoral immune response | TAS | biological_process |
GO:0006974 | Cellular response to DNA damage stimulus | IMP | biological_process |
GO:0007015 | Actin filament organization | IEA | biological_process |
GO:0007409 | Axonogenesis | IEA | biological_process |
GO:0007565 | Female pregnancy | NAS | biological_process |
GO:0007569 | Cell aging | IEA | biological_process |
GO:0008134 | Transcription factor binding | IEA | molecular_function |
GO:0008219 | Cell death | IDA | biological_process |
GO:0008584 | Male gonad development | IEA | biological_process |
GO:0008625 | Extrinsic apoptotic signaling pathway via death domain receptors | IDA | biological_process |
GO:0008630 | Intrinsic apoptotic signaling pathway in response to DNA damage | IBA | biological_process |
GO:0008631 | Intrinsic apoptotic signaling pathway in response to oxidative stress | IEA | biological_process |
GO:0009314 | Response to radiation | NAS | biological_process |
GO:0009636 | Response to toxic substance | IDA | biological_process |
GO:0009791 | Post-embryonic development | IEA | biological_process |
GO:0010039 | Response to iron ion | IDA | biological_process |
GO:0010224 | Response to UV-B | IEA | biological_process |
GO:0010332 | Response to gamma radiation | IEA | biological_process |
GO:0010507 | Negative regulation of autophagy | TAS | biological_process |
GO:0010523 | Negative regulation of calcium ion transport into cytosol | IEA | biological_process |
GO:0010559 | Regulation of glycoprotein biosynthetic process | IEA | biological_process |
GO:0014031 | Mesenchymal cell development | IEA | biological_process |
GO:0014042 | Positive regulation of neuron maturation | IEA | biological_process |
GO:0014911 | Positive regulation of smooth muscle cell migration | IEA | biological_process |
GO:0015267 | Channel activity | IDA | molecular_function |
GO:0016020 | Membrane | IDA | cellular_component |
GO:0016049 | Cell growth | IEA | biological_process |
GO:0016248 | Channel inhibitor activity | IDA | molecular_function |
GO:0016337 | Cell-cell adhesion | IEA | biological_process |
GO:0018105 | Peptidyl-serine phosphorylation | IEA | biological_process |
GO:0018107 | Peptidyl-threonine phosphorylation | IEA | biological_process |
GO:0021747 | Cochlear nucleus development | IEA | biological_process |
GO:0022612 | Gland morphogenesis | IEA | biological_process |
GO:0022898 | Regulation of transmembrane transporter activity | IDA | biological_process |
GO:0030279 | Negative regulation of ossification | IEA | biological_process |
GO:0030307 | Positive regulation of cell growth | IDA | biological_process |
GO:0030308 | Negative regulation of cell growth | IEA | biological_process |
GO:0030318 | Melanocyte differentiation | IEA | biological_process |
GO:0030336 | Negative regulation of cell migration | IEA | biological_process |
GO:0030890 | Positive regulation of B cell proliferation | IMP | biological_process |
GO:0031069 | Hair follicle morphogenesis | IEA | biological_process |
GO:0031103 | Axon regeneration | IEA | biological_process |
GO:0031625 | Ubiquitin protein ligase binding | IPI | molecular_function |
GO:0031647 | Regulation of protein stability | IEA | biological_process |
GO:0031965 | Nuclear membrane | IDA | cellular_component |
GO:0032469 | Endoplasmic reticulum calcium ion homeostasis | TAS | biological_process |
GO:0032835 | Glomerulus development | IEA | biological_process |
GO:0032848 | Negative regulation of cellular pH reduction | IDA | biological_process |
GO:0033033 | Negative regulation of myeloid cell apoptotic process | IEA | biological_process |
GO:0033077 | T cell differentiation in thymus | IEA | biological_process |
GO:0033138 | Positive regulation of peptidyl-serine phosphorylation | IEA | biological_process |
GO:0033689 | Negative regulation of osteoblast proliferation | IEA | biological_process |
GO:0034097 | Response to cytokine | IDA | biological_process |
GO:0035094 | Response to nicotine | IDA | biological_process |
GO:0035265 | Organ growth | IEA | biological_process |
GO:0035872 | Nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | TAS | biological_process |
GO:0040018 | Positive regulation of multicellular organism growth | IEA | biological_process |
GO:0042100 | B cell proliferation | IDA | biological_process |
GO:0042149 | Cellular response to glucose starvation | IEA | biological_process |
GO:0042493 | Response to drug | IDA IMP | biological_process |
GO:0042542 | Response to hydrogen peroxide | IEA | biological_process |
GO:0042802 | Identical protein binding | IPI | molecular_function |
GO:0042803 | Protein homodimerization activity | IPI | molecular_function |
GO:0043029 | T cell homeostasis | IEA | biological_process |
GO:0043066 | Negative regulation of apoptotic process | IDA IEA IMP | biological_process |
GO:0043085 | Positive regulation of catalytic activity | IEA | biological_process |
GO:0043209 | Myelin sheath | IEA | cellular_component |
GO:0043375 | CD8-positive, alpha-beta T cell lineage commitment | IEA | biological_process |
GO:0043496 | Regulation of protein homodimerization activity | IDA | biological_process |
GO:0043497 | Regulation of protein heterodimerization activity | IDA | biological_process |
GO:0043524 | Negative regulation of neuron apoptotic process | IDA | biological_process |
GO:0043565 | Sequence-specific DNA binding | IDA | molecular_function |
GO:0043583 | Ear development | IEA | biological_process |
GO:0045069 | Regulation of viral genome replication | IEA | biological_process |
GO:0045087 | Innate immune response | TAS | biological_process |
GO:0045636 | Positive regulation of melanocyte differentiation | IEA | biological_process |
GO:0045930 | Negative regulation of mitotic cell cycle | IEA | biological_process |
GO:0046671 | Negative regulation of retinal cell programmed cell death | IEA | biological_process |
GO:0046902 | Regulation of mitochondrial membrane permeability | ISS | biological_process |
GO:0046930 | Pore complex | IDA | cellular_component |
GO:0046982 | Protein heterodimerization activity | IPI | molecular_function |
GO:0048041 | Focal adhesion assembly | IEA | biological_process |
GO:0048536 | Spleen development | IEA | biological_process |
GO:0048538 | Thymus development | IEA | biological_process |
GO:0048546 | Digestive tract morphogenesis | IEA | biological_process |
GO:0048589 | Developmental growth | IEA | biological_process |
GO:0048599 | Oocyte development | IEA | biological_process |
GO:0048743 | Positive regulation of skeletal muscle fiber development | IEA | biological_process |
GO:0048753 | Pigment granule organization | IEA | biological_process |
GO:0048873 | Homeostasis of number of cells within a tissue | IEA | biological_process |
GO:0050853 | B cell receptor signaling pathway | IMP | biological_process |
GO:0051384 | Response to glucocorticoid | IEA | biological_process |
GO:0051402 | Neuron apoptotic process | TAS | biological_process |
GO:0051434 | BH3 domain binding | IPI | molecular_function |
GO:0051607 | Defense response to virus | IDA | biological_process |
GO:0051721 | Protein phosphatase 2A binding | IEA | molecular_function |
GO:0051881 | Regulation of mitochondrial membrane potential | ISS | biological_process |
GO:0051902 | Negative regulation of mitochondrial depolarization | TAS | biological_process |
GO:0051924 | Regulation of calcium ion transport | IDA | biological_process |
GO:0055085 | Transmembrane transport | IDA | biological_process |
GO:0070059 | Intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | IDA | biological_process |
GO:0071310 | Cellular response to organic substance | IEA | biological_process |
GO:0071456 | Cellular response to hypoxia | IEA | biological_process |
GO:0072593 | Reactive oxygen species metabolic process | IEA | biological_process |
GO:0097192 | Extrinsic apoptotic signaling pathway in absence of ligand | IEA | biological_process |
GO:0097193 | Intrinsic apoptotic signaling pathway | TAS | biological_process |
GO:1900740 | Positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | TAS | biological_process |
GO:2000134 | Negative regulation of G1/S transition of mitotic cell cycle | IEA | biological_process |
GO:2000811 | Negative regulation of anoikis | IMP | biological_process |
GO:2001234 | Negative regulation of apoptotic signaling pathway | IMP | biological_process |
GO:2001240 | Negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | IGI | biological_process |
GO:2001243 | Negative regulation of intrinsic apoptotic signaling pathway | IDA | biological_process |
GO:2001244 | Positive regulation of intrinsic apoptotic signaling pathway | TAS | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.9691563011 | 0.0930564264 | 0.9999902473 | 0.5809625712 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Down | -0.0160366161 |
GSE13712_SHEAR | Down | -0.1634935574 |
GSE13712_STATIC | Down | -0.1134116342 |
GSE19018 | Up | 0.0344740342 |
GSE19899_A1 | Up | 0.0319000596 |
GSE19899_A2 | Down | -0.1380993379 |
PubMed_21979375_A1 | Down | -0.2545400904 |
PubMed_21979375_A2 | Down | -0.2998400245 |
GSE35957 | Up | 0.0684299009 |
GSE36640 | Down | -0.4815283369 |
GSE54402 | Down | -0.1206334611 |
GSE9593 | Up | 0.1951049146 |
GSE43922 | Up | 0.0331802168 |
GSE24585 | Down | -1.0810074286 |
GSE37065 | Down | -0.0629539289 |
GSE28863_A1 | Down | -0.1514889125 |
GSE28863_A2 | Down | -0.1085914272 |
GSE28863_A3 | Up | 0.1331353191 |
GSE28863_A4 | Up | 0.0043604868 |
GSE48662 | Down | -0.0095496806 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Entries Per Page
Displaying Page of
- Drugs
Name | Drug | Accession number |
---|---|---|
Docetaxel | DB01248 | APRD00932 |
Rasagiline | DB01367 | EXPT02758 |
E7389 | DB04940 | - |
S-8184 | DB05281 | - |
DHA-paclitaxel | DB05297 | - |
ABT-263 | DB05764 | - |
Venetoclax | DB11581 | - |
- MicroRNAs
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-34b-5p | MIMAT0000685 | MIRT000065 | qRT-PCR//Luciferase reporter assay//Western blot | Functional MTI | 18803879 |
hsa-miR-21-5p | MIMAT0000076 | MIRT000159 | Luciferase reporter assay | Functional MTI | 17072344 |
hsa-miR-21-5p | MIMAT0000076 | MIRT000159 | qRT-PCR//Western blot | Non-Functional MTI | 22528454 |
hsa-miR-21-5p | MIMAT0000076 | MIRT000159 | Western blot | Functional MTI | 21468550 |
hsa-miR-21-5p | MIMAT0000076 | MIRT000159 | Western blot;Other | Functional MTI | 20048743 |
hsa-miR-204-5p | MIMAT0000265 | MIRT000192 | Luciferase reporter assay | Functional MTI | 19074899 |
hsa-miR-153-3p | MIMAT0000439 | MIRT000290 | Luciferase reporter assay//Western blot//Reporter assay | Functional MTI | 19676043 |
hsa-let-7a-5p | MIMAT0000062 | MIRT000418 | Microarray//qRT-PCR | Functional MTI (Weak) | 17260024 |
hsa-miR-15a-5p | MIMAT0000068 | MIRT000815 | qRT-PCR//proteomics analysis | Functional MTI (Weak) | 18362358 |
hsa-miR-15a-5p | MIMAT0000068 | MIRT000815 | Luciferase reporter assay | Functional MTI | 17707831 |
hsa-miR-15a-5p | MIMAT0000068 | MIRT000815 | Luciferase reporter assay | Functional MTI | 19478946 |
hsa-miR-15a-5p | MIMAT0000068 | MIRT000815 | Western blot | Functional MTI | 20876285 |
hsa-miR-15a-5p | MIMAT0000068 | MIRT000815 | Microarray//qRT-PCR | Functional MTI (Weak) | 17260024 |
hsa-miR-15a-5p | MIMAT0000068 | MIRT000815 | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 16166262 |
hsa-miR-15a-5p | MIMAT0000068 | MIRT000815 | Western blot | Functional MTI | 19903841 |
hsa-miR-15b-5p | MIMAT0000417 | MIRT000978 | Luciferase reporter assay//qRT-PCR//Western blot//Reporter assay//Reporter assay;Other | Functional MTI | 18449891 |
hsa-miR-365a-3p | MIMAT0000710 | MIRT006243 | Luciferase reporter assay//Western blot | Functional MTI | 22072615 |
hsa-miR-365a-3p | MIMAT0000710 | MIRT006243 | Western blot | Functional MTI | 21640710 |
hsa-miR-16-5p | MIMAT0000069 | MIRT001800 | Luciferase reporter assay | Functional MTI | 17877811 |
hsa-miR-16-5p | MIMAT0000069 | MIRT001800 | Luciferase reporter assay//qRT-PCR//Western blot//Reporter assay | Functional MTI | 18449891 |
hsa-miR-16-5p | MIMAT0000069 | MIRT001800 | qRT-PCR//proteomics analysis | Functional MTI (Weak) | 18362358 |
hsa-miR-16-5p | MIMAT0000069 | MIRT001800 | Luciferase reporter assay | Functional MTI | 17351108 |
hsa-miR-16-5p | MIMAT0000069 | MIRT001800 | Luciferase reporter assay | Functional MTI | 17707831 |
hsa-miR-16-5p | MIMAT0000069 | MIRT001800 | Immunohistochemistry//Microarray//Western blot | Functional MTI | 20643754 |
hsa-miR-16-5p | MIMAT0000069 | MIRT001800 | Western blot | Functional MTI | 20876285 |
hsa-miR-16-5p | MIMAT0000069 | MIRT001800 | Luciferase reporter assay//Western blot | Functional MTI | 19269153 |
hsa-miR-16-5p | MIMAT0000069 | MIRT001800 | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 16166262 |
hsa-miR-16-5p | MIMAT0000069 | MIRT001800 | Western blot | Functional MTI | 19903841 |
hsa-miR-16-5p | MIMAT0000069 | MIRT001800 | Sequencing | Functional MTI (Weak) | 20371350 |
hsa-miR-34a-5p | MIMAT0000255 | MIRT002298 | Luciferase reporter assay//qRT-PCR//Western blot//Reporter assay;Western blot;qRT-PCR;Other | Functional MTI | 19683563 |
hsa-miR-34a-5p | MIMAT0000255 | MIRT002298 | qRT-PCR//Western blot//Luciferase reporter assay | Functional MTI | 18505919 |
hsa-miR-34a-5p | MIMAT0000255 | MIRT002298 | qRT-PCR//Luciferase reporter assay//Western blot | Functional MTI | 18803879 |
hsa-miR-34a-5p | MIMAT0000255 | MIRT002298 | Luciferase reporter assay | Functional MTI | 19461653 |
hsa-miR-34a-5p | MIMAT0000255 | MIRT002298 | Luciferase reporter assay//Western blot//Microarray | Functional MTI | 17914404 |
hsa-miR-34a-5p | MIMAT0000255 | MIRT002298 | Luciferase reporter assay//Microarray//Western blot | Functional MTI | 17656095 |
hsa-miR-34a-5p | MIMAT0000255 | MIRT002298 | Flow//Immunoblot//Luciferase reporter assay//Reporter assay | Functional MTI | 20598588 |
hsa-miR-34a-5p | MIMAT0000255 | MIRT002298 | Reporter assay;Other | Functional MTI | 21399894 |
hsa-miR-34a-5p | MIMAT0000255 | MIRT002298 | Proteomics | Functional MTI (Weak) | 21566225 |
hsa-miR-20a-5p | MIMAT0000075 | MIRT003011 | Luciferase reporter assay | Functional MTI | 19666108 |
hsa-miR-17-5p | MIMAT0000070 | MIRT003014 | Luciferase reporter assay | Functional MTI | 19666108 |
hsa-miR-29c-3p | MIMAT0000681 | MIRT003289 | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 20041405 |
hsa-miR-29b-3p | MIMAT0000100 | MIRT003290 | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 20041405 |
hsa-miR-29a-3p | MIMAT0000086 | MIRT003291 | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 20041405 |
hsa-miR-181a-5p | MIMAT0000256 | MIRT003501 | Luciferase reporter assay//qRT-PCR//Western blot//Reporter assay;Western blot;Other | Functional MTI | 20162574 |
hsa-miR-181a-5p | MIMAT0000256 | MIRT003501 | Luciferase reporter assay | Functional MTI | 22285729 |
hsa-miR-181a-5p | MIMAT0000256 | MIRT003501 | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 22209977 |
hsa-miR-181a-5p | MIMAT0000256 | MIRT003501 | Immunoblot//Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 21958558 |
hsa-miR-181a-5p | MIMAT0000256 | MIRT003501 | Luciferase reporter assay | Functional MTI | 22610076 |
hsa-miR-181b-5p | MIMAT0000257 | MIRT003500 | Luciferase reporter assay//qRT-PCR//Western blot//Reporter assay;Western blot;Other | Functional MTI | 20162574 |
hsa-miR-181b-5p | MIMAT0000257 | MIRT003500 | Luciferase reporter assay | Functional MTI | 22610076 |
hsa-miR-181c-5p | MIMAT0000258 | MIRT003499 | Luciferase reporter assay//qRT-PCR//Western blot//Reporter assay;Western blot;Other | Functional MTI | 20162574 |
hsa-miR-181d-5p | MIMAT0002821 | MIRT003498 | Luciferase reporter assay//qRT-PCR//Western blot//Reporter assay;Western blot;Other | Functional MTI | 20162574 |
hsa-miR-181d-5p | MIMAT0002821 | MIRT003498 | FACS//Immunohistochemistry//Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 22207524 |
hsa-miR-125b-5p | MIMAT0000423 | MIRT006253 | Luciferase reporter assay//Western blot | Functional MTI | 22293115 |
hsa-miR-34c-5p | MIMAT0000686 | MIRT003979 | qRT-PCR//Luciferase reporter assay//Western blot | Functional MTI | 18803879 |
hsa-miR-192-5p | MIMAT0000222 | MIRT004844 | Luciferase reporter assay//qRT-PCR//Reporter assay;Microarray;Other | Functional MTI | 19074876 |
hsa-miR-195-5p | MIMAT0000461 | MIRT005362 | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 20727858 |
hsa-miR-630 | MIMAT0003299 | MIRT005578 | Immunoblot//Luciferase reporter assay//qRT-PCR | Functional MTI | 21274007 |
hsa-miR-451a | MIMAT0001631 | MIRT005744 | qRT-PCR//Western blot | Functional MTI | 20816946 |
hsa-miR-449a | MIMAT0001541 | MIRT006445 | ChIP-seq//Luciferase reporter assay | Functional MTI | 21569010 |
hsa-miR-200b-3p | MIMAT0000318 | MIRT006670 | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 21993663 |
hsa-miR-200c-3p | MIMAT0000617 | MIRT006673 | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 21993663 |
hsa-miR-429 | MIMAT0001536 | MIRT006674 | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 21993663 |
hsa-miR-136-5p | MIMAT0000448 | MIRT006868 | Luciferase reporter assay | Functional MTI | 22967897 |
hsa-miR-7-5p | MIMAT0000252 | MIRT006904 | GFP reporter assay//Luciferase reporter assay//qRT-PCR//Western blot//Reporter assay;Western blot;qRT-PCR;Other | Functional MTI | 21750649 |
hsa-miR-148a-3p | MIMAT0000243 | MIRT006975 | Luciferase reporter assay | Functional MTI | 21455217 |
hsa-miR-24-2-5p | MIMAT0004497 | MIRT006977 | Luciferase reporter assay | Functional MTI | 21463514 |
hsa-miR-182-5p | MIMAT0000259 | MIRT007063 | Flow//Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 22848417 |
hsa-miR-196b-5p | MIMAT0001080 | MIRT007146 | Immunocytochemistry | Functional MTI (Weak) | 23293219 |
hsa-miR-143-3p | MIMAT0000435 | MIRT007348 | Western blot | Functional MTI | 23276710 |
hsa-miR-143-3p | MIMAT0000435 | MIRT007348 | Western blot | Functional MTI | 19843160 |
hsa-miR-375 | MIMAT0000728 | MIRT019975 | qRT-PCR;Microarray | Functional MTI (Weak) | 20584986 |
hsa-miR-215-5p | MIMAT0000272 | MIRT024494 | Microarray | Functional MTI (Weak) | 19074876 |
hsa-miR-103a-3p | MIMAT0000101 | MIRT027158 | Sequencing | Functional MTI (Weak) | 20371350 |
hsa-miR-96-5p | MIMAT0000095 | MIRT027929 | Sequencing | Functional MTI (Weak) | 20371350 |
Entries Per Page
Displaying Page of
- mirRecord
MicroRNA name | mirBase ID | Target site number | MiRNA mature ID | Test method inter | MiRNA regulation site | Reporter target site | Pubmed ID |
---|---|---|---|---|---|---|---|
hsa-miR-15a-5p | MIMAT0000068 | 1 | hsa-miR-15a | {Western blot} | {overexpression by mature miRNA transfection} | 16166262 | |
hsa-miR-16-5p | MIMAT0000069 | 1 | hsa-miR-16 | {Western blot} | {overexpression by mature miRNA transfection} | 16166262 | |
hsa-miR-16-5p | MIMAT0000069 | 1 | hsa-miR-16 | 17877811 | |||
hsa-miR-34a-5p | MIMAT0000255 | 1 | hsa-miR-34a | {Western blot} | {underexpression by LNA antisense miRNA oligonucleotides} | 17656095 | |
hsa-miR-16-5p | MIMAT0000069 | 1 | hsa-miR-16 | {Western blot} | {overexpression by miRNA precursor transfection} | 18449891 | |
hsa-miR-15b-5p | MIMAT0000417 | 1 | hsa-miR-15b | {Western blot} | {overexpression by miRNA precursor transfection} | 18449891 | |
hsa-miR-15a-5p | MIMAT0000068 | NA | hsa-miR-15a | 18362358 | |||
hsa-miR-16-5p | MIMAT0000069 | NA | hsa-miR-16 | 18362358 | |||
hsa-miR-16-5p | MIMAT0000069 | NA | hsa-miR-16 | proteomics analysis | overexpression | 18362358 | |
hsa-miR-15a-5p | MIMAT0000068 | NA | hsa-miR-15a | {phenotypic analysis of target gene} | {overexpression} | 18362358 | |
hsa-miR-34a-5p | MIMAT0000255 | NA | hsa-miR-34a | {Western blot} | {overexpression by miRNA precursor transfection} | 18834855 | |
hsa-miR-16-5p | MIMAT0000069 | NA | hsa-miR-16 | {Western blot} | {overexpression by miRNA precursor transfection} | 19269153 | |
hsa-miR-296-5p | MIMAT0000690 | NA | hsa-miR-296-5p | {Western blot} | {downregulation} | 20485139 | |
hsa-miR-181a-5p | MIMAT0000256 | NA | hsa-miR-181a | {Western blot} | {overexpression by miRNA mimics tranfection} | 20204284 | |
hsa-miR-1 | MIMAT0000416 | 1 | hsa-miR-1 | {Western blot} | {overexpression} | 19506341 | |
hsa-miR-143-3p | MIMAT0000435 | 1 | hsa-miR-143 | {Western blot} | {overexpression by miRNA precursor transfection} | 20878132 | |
hsa-miR-143-3p | MIMAT0000435 | 2 | hsa-miR-143 | {Western blot} | {overexpression by miRNA precursor transfection} | 20878132 |
Entries Per Page
Displaying Page of
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 55 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
27212655 | The oxidative stress-sensitive proteins ataxia-telangiectasia mutated and p53 were phosphorylated, and the expression of apoptosis molecules Bax increased, and Bcl-2 decreased in early passage MSCs; however, the expression of the apoptotic molecules did less change in response to apoptotic stimulation in late-passage MSCs, suggesting that the intrinsic apoptotic signalling pathway was not induced by oxidative stress in long-term-cultured MSCs |
27208501 | Mechanistically, TIS21(/BTG2) regulated posttranslational modification of p53 via enhancing miR34a and Bax expressions as opposed to inhibiting SIRT1 and Bcl2 expression |
26711051 | N targets Bcl-2, Bcl-xl, and Bcl-w, while T targets Bcl-2, Bcl-xl, and Mcl-1 |
26711051 | The combination of Bcl-2, Bcl-xl, and Bcl-w siRNAs was senolytic in HUVECs and IMR90 cells, while combination of Bcl-2, Bcl-xl, and Mcl-1 siRNAs was not |
26687460 | PEAM-injected IVDs showed significantly higher BAX/BCL2 ratio vs sham-injected IVDs suggestive of an anti-apoptotic effect of the PEAMs |
26657143 | To test this idea, we screened a collection of compounds and identified ABT263 (a specific inhibitor of the anti-apoptotic proteins BCL-2 and BCL-xL) as a potent senolytic drug |
26437300 | Decreased protein levels of the shelterin subunits, shortened telomere length, over-expressed Ki-67, and Bcl2 as well as mutations in P53 were detected both in MGC and BCC |
26437300 | However, several parameters distinguish MGC from BCC samples: (i) the mRNA level of the shelterin subunits decreased in MGC but it increased in BCC; (ii) P53 was more highly mutated in MGC; (iii) Siah1 mRNA was over-expressed in BCC; (iv) BCC samples contain a higher level of senescent cells; (v) Ki-67 and Bcl2 expression were lower in BCC |
25895748 | Protein expression relating to apoptosis (Bax, Bcl-2, Survivin), autophagy (Beclin-1, LC3B) and cellular senescence (p21, p16) was evaluated using indirect immunofluorescence |
25882843 | Alternately, Mito-Pim1 enhances survival by increasing expression of Bcl-2 and Bcl-XL and decreasing cell death after H2O2 treatment, thereby preserving mitochondrial integrity superior to PimWT |
25777063 | The molecular mechanisms involve substrate competition of tau and beta-catenin for glycogen synthase kinase 3beta (GSK-3beta); activation of Akt; preservation of Bcl-2 and suppression of Bax, cytosolic cytochrome-c, and caspase-3 activity; and upregulation of unfolded protein response (UPR), i |
25540416 | EBNA2 and EBNALP associate with EBV and cell enhancers, up-regulate the EBNA promoter, MYC, and EBV Latent infection Membrane Proteins (LMPs), which up-regulate BCL2 to protect EBV-infected B-cells from MYC proliferation-induced cell death |
25540416 | EBNA3A was at MYC, CDKN2A/B, CCND2, CXCL9/10, and BCL2, together with RUNX3, BATF, IRF4, and SPI1 |
25481090 | In addition, the protein levels of p-AKT, p-ERK, Bcl-2, matrix metallopeptidase 9 (MMP-9) and fibronectin (FN) were significantly reduced following quercetin treatment |
25440825 | Apoptotic indices of smooth muscle cells and Bcl-2 were significantly greater at the site of UPJO (5 |
25333784 | Expression levels of Bcl-2 and Bax proteins were measured by western blot analysis |
25333784 | LBPs also inhibited H2O2-induced downregulated Bcl-2 and upregulated Bax proteins and increased the levels of SOD and GSH enzyme activity |
24673471 | Beclin-1 was indispensable to Ang II-induced autophagy, and its BH3 domain was required for the interaction with Bcl-2 to attenuate autophagy |
24607549 | Among these, Bcl-2 family members--which are critically involved in maintaining mitochondrial integrity--may play a role in controlling mitochondrial function and dysfunction during cellular aging, also considering that Bcl-2, the master member of the family, is an anti-oxidant and anti-apoptotic factor and regulates mitochondrial fission/fusion and autophagy |
24607549 | This intriguing hypothesis is supported by several observations: i) in endothelial cells undergoing replicative senescence (HUVECs), a well-established model of cell senescence, miR-146a, miR-34a, and miR-181a are over-expressed whereas their target Bcl-2 is down-regulated; ii) IPA of the miR-146a, miR-34a and miR-181a network shows that they are closely linked to each other, to Bcl-2 and to mitochondria; and iii) miR-146a, miR-34a, and miR-181a are involved in important cell functions (growth, proliferation, death, survival, maintenance) and age-related diseases (cancer, skeletal and muscle disorders, neurological, cardiovascular and metabolic diseases) |
24475256 | Surprisingly, under self-renewing culture conditions, some of these senescent cells undergo p53-independent apoptosis, which can be suppressed by caspase inhibition and BCL2 overexpression |
24024133 | Senescent HDFs are more resistant to oxidative stress (exogenous H2O2)-induced apoptosis in comparison to non-senescent (control) HDFs; this is associated with constitutively high levels of the anti-apoptotic gene, Bcl-2, and low expression of the pro-apoptotic gene, Bax |
24024133 | In contrast to Bax gene, chromatin immunoprecipitation studies demonstrate marked enrichment of the Bcl-2 gene with H4K16Ac, and depletion with H4K20Me3, predicting active transcription of this gene in senescent HDFs |
23984931 | After tBHP treatment, Bcl-2 protein expression decreased and Bax protein expression increased |
23984931 | Bax protein expression decreased, but Bcl-2 protein expression increased after AG490 and probucol treatment |
23907579 | Treatment of gastric cancer cells with DHA increased miR-15b and miR-16 expression, caused a downregulation of Bcl-2, resulting in apoptosis of gastric cancer cells |
23807740 | Expression profiles of certain relevant genes and proteins like p53, Akt, Bcl-2, Bax, cytochrome c and caspase 3 also provided evidence of ROS mediated p53 up-regulation and further boost in Bax expression and followed by cytochrome c release and activation of caspase 3 |
22919441 | Gene expression analysis showed that GTT treatment down regulated BAX mRNA, up-regulated BCL2A1 mRNA and decreased the ratio of Bax/Bcl-2 protein expression (P < 0 |
22899934 | On the other hand, the expression of inhibitory Bcl-2/xL proteins increases with aging |
22898871 | Inhibition of apoptosis by targeting Bim expression or overexpression of Bcl2 potentiates senescence |
22898871 | In contrast, in apoptotic-deficient cells (Bim expression or overexpression of Bcl2), the inhibition of autophagy did not significantly modify the SA-beta-Gal-positive cell population |
21909125 | The expression of apoptosis-associated proteins, such as p53, p21, Bcl-2, and Bax, did not significantly change in the presence of H(2)O(2) (100 mumol/L) or RHL (10 mumol/L) |
21730299 | Here, we report a crucial role of Bcl-2 in the impaired angiogenic functions in senescent endothelial cells (ECs) by modulating the mitochondrial redox state |
21730299 | We identified that Bcl-2 expression was markedly reduced in 3 independent models for senescent ECs, and pharmacological inhibition, as well as small interfering RNA-mediated gene silencing of Bcl-2, significantly impaired the angiogenic functions in young ECs |
21730299 | Bcl-2 has an antioxidative role by locating the glutathione at mitochondria, and we found that mitochondrial oxidative stress was significantly augmented in senescent ECs, in association with reduced mitochondria-associated glutathione |
21730299 | Transfection of Bcl-2 in senescent ECs significantly reduced the mitochondrial oxidative stress, restored the mitochondrial membrane potential, and improved the angiogenic capacity |
21730299 | Furthermore, gene transfer of Bcl-2 using adenovirus significantly improved the in vivo angiogenesis in the Matrigel plugs implanted into aged mice, whereas the Bcl-2 inhibitor reduced the angiogenesis in the Matrigel plugs implanted into young mice |
21730299 | Together, Bcl-2 plays a crucial role in the regulation of the mitochondrial redox state in ECs, and, thus, loss of Bcl-2 during the senescence exacerbates the impaired angiogenesis by augmenting the mitochondrial oxidative stress |
21698300 | Compared to early cultures, late passage HUVECs also exhibited nuclear translocation of NF-kappaB (p65) and reciprocal shifts in BAX and BCL2 protein content resulting in almost 2-fold increase in BAX/BCL2 ratio and 3-fold increase in apoptotic response to TNFalpha exposure (p<0 |
21212468 | Remarkably, overexpressed Zfra induces apoptosis via the mitochondrial pathway, which involves suppression of Bcl-2 and Bcl-xL expression (without causing cytochrome c release), counteracting the apoptotic function of tumor suppressor p53 and WWOX, and dissipation of mitochondrial membrane potential for ultimately leading to cell death |
21182935 | Similarly, UVB-induced translocation of Bax and Bcl-2 to mitochondria and cytosol, respectively, was markedly attenuated in cells overexpressing AR |
21084274 | ABT-737, a small molecule cell-permeable Bcl-2 antagonist that acts by mimicking BH3 proteins, induces apoptotic cell death in multiple cancer types |
20969773 | P16INK4a was downregulated, p53 was low expressed and Bax/Bcl-2 ratio was reversed |
20729911 | Unlike PTX, knockdown of TACC3 did not trigger a cell death response, but instead resulted in a progressive loss of the pro-apoptotic Bcl-2 protein Bim that links microtubule integrity to spindle poison-induced cell death |
20703098 | Importantly, p53(R172P) MEFs failed to downregulate anti-apoptotic protein Bcl-2, which has been shown to play an important role in p53-dependent apoptosis |
19653337 | The relative expression level of Bcl-2 dropped to less than 50% of control cells at a sub-apoptotic concentration of chelidonine and subsequently increased to higher than 120% at LD(50) |
19147823 | In contrast, the expression of several proteins involved in the regulation of macroautophagy, notably Beclin-1 and Bcl-2, was found to change with senescence |
18694296 | Both SAHA and MS-275 induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of Bax/Bcl-2 expression |
18158869 | METHODS: BMMS-03 cells and hMSC from the bone marrow of a 4-month-old elicited fetus, were transiently transfected with the pcDNA3-hbxip plasmid encoding the HBXIP gene and pSilencer-hbxip plasmid encoding RNA interference (RNAi) targeting HBXIP mRNA, followed by the examination of the hTERT promoter reporter gene by luciferase assay, and the detection of telomerase activity by telomeric repeat amplication protocol, respectively, as well as the expression levels of hTERT, c-Myc, and Bcl-2 by Western blot analysis |
18158869 | RESULTS: The overexpression of HBXIP led to a significant upregulation of hTERT promoter activity, telomerase activity, and the expression levels of hTERT, c-Myc, and Bcl-2 in BMMS-03 cells |
18060755 | Also, DHA and PEDF synergistically activate NPD1 synthesis and antiapoptotic protein expression and decreased proapoptotic Bcl-2 protein expression and caspase 3 activation during oxidative stress |
18060755 | The Bcl-2 pro- and antiapoptotic proteins, neurotrophins, and NPD1, lie along a cell fate-regulatory pathway whose component members are highly interactive, and have potential to function cooperatively in cell survival |
17882791 | By blocking apoptosis, Bcl-2 in p38-dependent manner promotes cell cycle arrest and accelerated senescence after DNA damage and serum withdrawal |
17433785 | Expression of Bcl2 blocked apoptosis in tumor cells, but surprisingly, mice with short telomeres were still resistant to tumor formation |
16711390 | Bcl-2 introduction in E1A + c-Ha-ras-transformants is accompanied by a rise of SA beta-Gal (Senescence Associated beta-Galactosidase) activity, which is commonly considered to be a marker of cell senescence |
16711390 | Co-immunoprecipitation experiments demonstrated the introduction of Bcl-2 to result in formation of Bcl-2 complexes with early region E1A oncoproducts, which are thought to be responsible for proapoptotic susceptibility of E1A-expressing transformants |
16711390 | The data obtained lead to suggestion that bcl-2 transfer to E1A + c-Ha-ras-transformants may induce a switch from the cell death program on the program of senescence after DNA damage, due, presumably, to Bcl-2 interaction with the apoptosis activator the viral oncoprotein E1A |
16705698 | Apoptosis does not appear to be a major determinant of doxorubicin-induced mortality in FU-SY-1 SS or NHDF cultures, but may impact SW982 cells via the overexpression of BAX relative to Bcl-2 |
16545683 | Bcl-2 protects against oxidative stress while inducing premature senescence |
16545683 | The former suggests a molecular link between cell cycle regulation and cell survival that could involve regulatory proteins such as Bcl-2 |
16545683 | There is strong evidence that, in addition to its well-known effects on apoptosis, Bcl-2 is involved in antioxidant protection and regulation of cell cycle progression |
16545683 | The aim of this work was to determine if the protection against oxidative stress mediated by Bcl-2 could prevent or delay oxidative stress-induced senescence |
16545683 | Fibroblasts overexpressing Bcl-2 were exposed to 75 microM H2O2 for 2 h to induce SIPS |
16545683 | Our results indicate that overexpression of Bcl-2 protected primary fibroblasts against oxidative stress-mediated reduction in cell proliferation, but did not prevent premature senescence |
15922292 | Unknotting the roles of Bcl-2 and Bcl-xL in cell death |
15922292 | The antiapoptotic Bcl-2 family proteins Bcl-2 and Bcl-xL play important roles in inhibiting mitochondria-dependent extrinsic and intrinsic cell death pathways |
15922292 | The overexpression of Bcl-2 is able to inhibit not only apoptotic cell death but also in part nonapoptotic cell death, which has the role of cell cycle arrest in the G1 phase, which may promote cellular senescence |
15922292 | The overexpression of Bcl-2 may also have the ability to enhance cell death in the interaction of Bcl-xL with other factors |
15922292 | This review discusses the previously unexplained aspects of Bcl-2 and Bcl-xL functions associated with cell death, for better understanding of their functions in the regulation |
15013668 | Furthermore, we found that while the pro-apoptotic p53 increased, the anti-apoptotic Bcl-2 declined |
14653227 | Pro-death Bax increased, while anti-death Bcl-2 and Bcl-XL decreased, and apoptotic TUNEL-positive cells were detected in the hippocampus of klotho mutant mice at the age of 7 weeks |
12959928 | Senescent BMP4-treated cells had lower ERK activation, VEGF expression, and Bcl2 expression than wild-type cells, consistent with a less proliferative, less angiogenic phenotype with increased susceptibility to death by apoptosis |
12473065 | Similarities between preparations included: an enhanced ability for both Apo2L/TRAIL preparations to kill a greater relative percentage of HaCaT cells compared with keratinocytes; enhanced cytotoxicity towards keratinocytes that had their NF-B activity inhibited; a dependence of both Apo2L/TRAIL preparations on FADD and caspase activation; triggering of the same caspase cascades including caspase 8 and 3; and an ability to induce apoptosis even when HaCaT cells and keratinocytes were transduced to overexpress either Bcl-2 or Bcl-x(L) (survival factors that reduce susceptibility to UV-light-induced apoptosis) |
12473065 | Moreover, the death receptor pathway triggered by LZ-Apo2L/TRAIL can overcome the apoptotic resistance normally observed in response to UV-light mediated by Bcl-2/Bcl-x(L), as well as by the state of cellular senescence |
12469202 | Bcl-2 in cancer and normal tissue cells as a prediction marker of response to 5-fluorouracil |
12469202 | Bcl-2 in cancer cells was shown to be a potent indicator of 5-FU efficacy, but the protein in normal tissue cells appeared not to be a marker of 5-FU toxicity probably due to the functional alteration of Bcl-2 associated with cell senescence |
12469202 | Transfection analysis of Bcl-2-S and Bcl-2-AS into A549 lung cancer cells revealed that Bcl-2 suppressed cell death induced by 5-FU, and the gene expression level of Bcl-2 was closely correlated with the IC50 for 5-FU in 21 fresh human gastric tumor specimens |
12469202 | Transfection analysis of Bcl-2-S and Bcl-2-AS into MJ90 cells showed that Bcl-2 correlated with the resistance to 5-FU in the transfectants at PDL60 as in A549 cells, but increased Bcl-2 in the PDL72 senescent transfectant did not cause an increase of the resistance to 5-FU |
12469202 | Cell aging was observed in MJ90 cells and Bcl-2 in the cells was found to decrease with the cell senescence |
11850025 | Steady state levels of Bcl-2, an anti-apoptotic protein, in senescent prolonged cultures decreased to less than 20% for all time points compared with young cells |
11850025 | These results indicate that terminal cellular aging enhances apoptosis and the levels of Bcl-2/Bad may be associated with the apoptotic process in porcine lung endothelial cells |
11642719 | Bcl2 expression was mainly seen in medullary thymocytes, reflecting the surviving thymocytes in this region |
11557274 | Senescent cells are resistant to death despite low Bcl-2 level |
11557274 | Bcl-2 is a product of the oncogene, bcl-2, but it may also participate in cellular senescence |
11557274 | To investigate the role of Bcl-2, we analyzed the level of Bcl-2 during aging of normal human fibroblasts by immunoblot analysis and found that its level was highly suppressed in four normal senescent fibroblast strains |
11480555 | Ceramide activation of protein phosphatases has been shown to promote inactivation of a number of pro-growth cellular regulators including the kinases PKC alpha and Akt, Bcl2 and the retinoblastoma protein |
10593857 | Several proto-oncogenes and tumor suppressor genes have been implicated in the regulation of telomerase activity, both directly and indirectly; these include c-Myc, Bcl-2, p21(WAF1), Rb, p53, PKC, Akt/PKB, and protein phosphatase 2A |
10438583 | Effects of differential overexpression of Bcl-2 on apoptosis, proliferation, and telomerase activity in Jurkat T cells |
10438583 | The effects of Bcl-2 overexpression on several of its multifunctional characteristics, which include anti-apoptotic properties, impeding of cell proliferation, and telomerase activity, were examined in four Jurkat T cell clones overexpressing different levels of Bcl-2 |
10438583 | When treated with anti-Fas or staurosporine, only three of the four clones showed resistance to apoptosis that correlated with the level of Bcl-2 expression |
10438583 | Surprisingly, the clone having no anti-apoptotic characteristic expressed the highest level of Bcl-2 |
10438583 | When all the clones were treated with anti-Fas the processing of caspase-2, -3, and -7 but not -8 was inhibited in the resistant clones to a similar extent by the differential overexpression of Bcl-2 |
10438583 | However, with staurosporine treatment the processing of all the caspases examined was inhibited to a similar degree by the different levels of Bcl-2 expression in the resistant clones |
10438583 | These results suggest that Bcl-2 blocked Fas-mediated cell death by acting downstream of caspase-8, which is in contrast to staurosporine-induced apoptosis where Bcl-2 is acting upstream of caspase-8 |
10438583 | When the anti-proliferative effect of Bcl-2 was examined, a direct correlation between a decrease in cell proliferation and the level of Bcl-2 overexpressed in the clones was observed |
10438583 | The clone overexpressing the greatest amount of Bcl-2 protein, which had no resistance to apoptosis, had the slowest proliferative rate |
10438583 | This suggests that the anti-apoptotic effect of Bcl-2 can be separated from its anti-proliferative effect |
10438583 | The possible effect of overexpression of Bcl-2 on telomerase activity, which is known to control the proliferative capacity of normal cells and cellular senescence, was also determined |
10438583 | Our results suggest that Bcl-2 had no effect on telomerase activity or telomere length in the clones |
10438583 | In summary, our results further suggest that some properties of Bcl-2, such as anti-apoptotic and inhibition of cell proliferation, are individual features of a multifaceted protein |
10066788 | Overexpression of Bcl-2 and the caspase inhibitor zVAD-fmk protected cells against apoptosis in the presence of telomerase inhibitors, suggesting a site of action of telomerase prior to caspase activation and mitochondrial dysfunction |
Entries Per Page
Displaying Page of